| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | HDAC5 GATAD2A PPRC1 MED14 GON4L SSX6P JADE1 MED13L KLHL22 SRRT NCOR1 KMT2C JUND IGF2BP1 IGF2BP3 MRTFB AP2A1 SNAP91 TRIM28 BRD4 BRD7 GAB3 RERE MED13 | 2.17e-06 | 1160 | 142 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | transcription coregulator activity | HDAC5 PPRC1 MED14 GON4L SSX6P JADE1 MED13L NCOR1 KMT2C JUND MRTFB TRIM28 BRD4 BRD7 RERE MED13 | 2.58e-06 | 562 | 142 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | HDAC5 GATAD2A PPRC1 MED14 GON4L SSX6P JADE1 MED13L KLHL22 SRRT NCOR1 KMT2C JUND IGF2BP1 IGF2BP3 MRTFB AP2A1 SNAP91 TRIM28 BRD4 PDE4DIP BRD7 GAB3 RERE MED13 | 9.88e-06 | 1356 | 142 | 25 | GO:0060090 |
| GeneOntologyMolecularFunction | transcription coactivator activity | PPRC1 MED14 JADE1 KMT2C JUND MRTFB TRIM28 BRD4 BRD7 RERE MED13 | 1.12e-05 | 303 | 142 | 11 | GO:0003713 |
| GeneOntologyMolecularFunction | isomerase activity | 4.54e-04 | 192 | 142 | 7 | GO:0016853 | |
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 4.95e-04 | 5 | 142 | 2 | GO:0035731 | |
| GeneOntologyCellularComponent | chromatin | FOXS1 HDAC5 GATAD2A BCL7C DRGX NPAS3 NAP1L3 GON4L JADE1 STAT6 NCOR1 KDM4D JUND PRDM10 BBX TRIM28 NFIB BRD4 BRPF1 BRD7 NKX2-2 NKX3-1 INO80B CREB3L2 | 8.15e-05 | 1480 | 145 | 24 | GO:0000785 |
| GeneOntologyCellularComponent | axoneme | 1.01e-04 | 207 | 145 | 8 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.04e-04 | 208 | 145 | 8 | GO:0097014 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 3.15e-04 | 85 | 145 | 5 | GO:0000118 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.78e-04 | 317 | 145 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | cilium | CCP110 MAP4 STARD10 PCDHB15 TOGARAM1 SSX6P JADE1 NME8 TTLL7 GLI1 PCDH15 FHDC1 CFAP161 HYDIN CFAP46 BRWD1 | 5.11e-04 | 898 | 145 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.52e-04 | 96 | 145 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | actin-based cell projection | 7.33e-04 | 278 | 145 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | cytoplasmic region | 9.38e-04 | 360 | 145 | 9 | GO:0099568 | |
| Domain | BROMODOMAIN_1 | 8.48e-06 | 37 | 142 | 5 | PS00633 | |
| Domain | BROMODOMAIN_2 | 1.42e-05 | 41 | 142 | 5 | PS50014 | |
| Domain | Bromodomain | 1.61e-05 | 42 | 142 | 5 | IPR001487 | |
| Domain | BROMO | 1.61e-05 | 42 | 142 | 5 | SM00297 | |
| Domain | - | 1.61e-05 | 42 | 142 | 5 | 1.20.920.10 | |
| Domain | Med13_N | 5.74e-05 | 2 | 142 | 2 | PF11597 | |
| Domain | Mediator_Med13_N_met/fun | 5.74e-05 | 2 | 142 | 2 | IPR021643 | |
| Domain | Med13_C | 5.74e-05 | 2 | 142 | 2 | PF06333 | |
| Domain | Mediator_Med13 | 5.74e-05 | 2 | 142 | 2 | IPR009401 | |
| Domain | Bromodomain | 1.93e-04 | 38 | 142 | 4 | PF00439 | |
| Domain | Znf_PHD-finger | 3.40e-04 | 79 | 142 | 5 | IPR019787 | |
| Domain | SANT | 5.62e-04 | 50 | 142 | 4 | SM00717 | |
| Domain | GST_alpha | 5.65e-04 | 5 | 142 | 2 | IPR003080 | |
| Domain | PHD | 5.89e-04 | 89 | 142 | 5 | SM00249 | |
| Domain | EPHD | 5.96e-04 | 22 | 142 | 3 | PS51805 | |
| Domain | Znf_PHD | 6.52e-04 | 91 | 142 | 5 | IPR001965 | |
| Domain | SANT/Myb | 6.53e-04 | 52 | 142 | 4 | IPR001005 | |
| Domain | ZF_PHD_2 | 7.92e-04 | 95 | 142 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 8.31e-04 | 96 | 142 | 5 | PS01359 | |
| Domain | Bromodomain_CS | 9.84e-04 | 26 | 142 | 3 | IPR018359 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NRF1 PPRC1 PIEZO1 MED14 JADE1 TNRC6C MED13L PLXNB2 NHSL1 NCOR1 KMT2C ZNF263 JUND SH3PXD2B AP2A1 ADAMTS7 PLEKHM2 TRIM28 GLI1 BRD4 PPP1R15B MED13 AHNAK2 | 2.56e-10 | 1105 | 146 | 23 | 35748872 |
| Pubmed | Interaction network of human early embryonic transcription factors. | HDAC5 BCL7C MECOM UBN2 NCOR1 KMT2C ZNF263 TAF3 ZNF608 NFIB BRD7 RERE TOP2A | 3.43e-09 | 351 | 146 | 13 | 38297188 |
| Pubmed | BCL7C MED14 MED13L UBN2 NCOR1 ZNF608 NFIB BRD4 BRD7 RERE MED13 | 2.03e-08 | 268 | 146 | 11 | 33640491 | |
| Pubmed | ZC3H14 MAP4 MED14 UBN2 SCYL2 NCOR1 KMT2C SH3PXD2B TAF3 MRTFB TRIM28 BRD4 PRRC2A TOP2A | 9.08e-08 | 549 | 146 | 14 | 38280479 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZC3H14 GATAD2A MAP4 ZC3H13 UBN2 CDCA8 SRRT NCOR1 IGF2BP1 TAF3 BBX SNAP91 TRIM28 BRD4 BRD7 PRRC2A TOP2A INO80B | 1.16e-07 | 954 | 146 | 18 | 36373674 |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 3.57e-07 | 35 | 146 | 5 | 26091241 | |
| Pubmed | HDAC5 GATAD2A BCL7C GON4L MECOM TNRC6C UBN2 SRRT NCOR1 KMT2C JUND IGF2BP1 IGF2BP3 TAF3 BBX ZNF608 NFIB BRD7 RERE PRRC2A INO80B | 6.05e-07 | 1429 | 146 | 21 | 35140242 | |
| Pubmed | MPP2 FKBP15 CACNB4 DSCAM UBN2 RTN1 ITIH1 NCOR1 ZNF263 SH3PXD2B AP2A1 SNAP91 TRIM28 PDE4DIP BRD7 MACF1 PRRC2A | 6.74e-07 | 963 | 146 | 17 | 28671696 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXS1 HDAC5 GATAD2A NRF1 NPAS3 MECOM E4F1 TTLL7 CRACD NCOR1 JUND PRDM10 BBX GLI1 TOP2A NOVA2 | 7.09e-07 | 857 | 146 | 16 | 25609649 |
| Pubmed | CCP110 ZC3H14 HDAC5 GATAD2A BCL7C KMT2C TAF3 TRIM28 BRD4 BRD7 HYDIN TOP2A | 7.58e-07 | 469 | 146 | 12 | 27634302 | |
| Pubmed | 7.83e-07 | 75 | 146 | 6 | 25593309 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MAP4 ZC3H13 BCL7C MED14 SRRT NCOR1 JUND TAF3 TRIM28 BRD4 BRPF1 RERE PRRC2A TOP2A MED13 | 1.02e-06 | 774 | 146 | 15 | 15302935 |
| Pubmed | GATAD2A BTBD18 BCL7C MECOM ZKSCAN2 TAF3 ZNF608 TRIM28 BRD4 BRPF1 BRD7 MACF1 RERE TOP2A INO80B CDH16 NOVA2 BRWD1 | 1.13e-06 | 1116 | 146 | 18 | 31753913 | |
| Pubmed | FKBP15 HDAC5 PPRC1 GON4L TNRC6C MED13L CRACD PLEKHM2 PDE4DIP MACF1 RERE | 1.31e-06 | 407 | 146 | 11 | 12693553 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXS1 DRGX NPAS3 GON4L ZKSCAN2 E4F1 STAT6 JUND BBX MZF1 NFIB GLI1 NKX2-2 NKX3-1 RERE CREB3L2 | 1.50e-06 | 908 | 146 | 16 | 19274049 |
| Pubmed | TOM1L2 MPP2 CACNB4 MAP4 SRCIN1 RTN1 AP2A1 SNAP91 MACF1 PRRC2A | 2.29e-06 | 347 | 146 | 10 | 17114649 | |
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 2.97e-06 | 53 | 146 | 5 | 15572359 | |
| Pubmed | 3.08e-06 | 209 | 146 | 8 | 36779422 | ||
| Pubmed | ZC3H14 MAP4 PIEZO1 MED14 GON4L E4F1 UBN2 SRRT CRACD KMT2C MRTFB BBX NFIB NMT2 BRD7 MACF1 INTS9 PRRC2A MED13 INO80B | 4.85e-06 | 1497 | 146 | 20 | 31527615 | |
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 5.08e-06 | 59 | 146 | 5 | 28813667 | |
| Pubmed | 5.31e-06 | 225 | 146 | 8 | 12168954 | ||
| Pubmed | Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2. | 5.98e-06 | 9 | 146 | 3 | 23144817 | |
| Pubmed | 7.07e-06 | 234 | 146 | 8 | 36243803 | ||
| Pubmed | TOM1L2 E4F1 SCYL2 NCOR1 MTMR11 MRTFB MAST4 AP2A1 BRD4 PPP1R15B PDE4DIP MACF1 | 8.10e-06 | 591 | 146 | 12 | 15231748 | |
| Pubmed | 8.51e-06 | 10 | 146 | 3 | 15870285 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 8.51e-06 | 10 | 146 | 3 | 23746844 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H14 GATAD2A ZC3H13 MECOM E4F1 UBN2 SRRT NCOR1 KMT2C JUND BBX AP2A1 TRIM28 NFIB BRD4 INTS9 TOP2A CREB3L2 | 8.76e-06 | 1294 | 146 | 18 | 30804502 |
| Pubmed | The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically. | 8.85e-06 | 66 | 146 | 5 | 32051553 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | GATAD2A BCL7C UBN2 CDCA8 TAF3 BBX BRD4 BRPF1 BRD7 ZNF649 TOP2A BRWD1 | 1.07e-05 | 608 | 146 | 12 | 36089195 |
| Pubmed | CCP110 HDAC5 ZC3H13 PIEZO1 PAQR8 DAG1 RUSC1 GON4L MECOM KIAA1191 PLXNB2 SCYL2 ZNF608 MED13 INO80B CFAP46 CREB3L2 | 1.47e-05 | 1215 | 146 | 17 | 15146197 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | GATAD2A BCL7C MED14 TAF3 BBX AP2A1 TRIM28 BRD4 INTS9 TOP2A NOVA2 | 1.68e-05 | 533 | 146 | 11 | 30554943 |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11668220 | ||
| Pubmed | Human liver glutathione S-transferases: complete primary sequence of an Ha subunit cDNA. | 1.75e-05 | 2 | 146 | 2 | 3800996 | |
| Pubmed | Nucleotide sequence of the human liver glutathione S-transferase subunit 1 cDNA. | 1.75e-05 | 2 | 146 | 2 | 3678589 | |
| Pubmed | The basic glutathione S-transferases from human livers are products of separate genes. | 1.75e-05 | 2 | 146 | 2 | 3036131 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 24940003 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21163259 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15128049 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 29343442 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11692074 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 30790682 | ||
| Pubmed | FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway. | 1.75e-05 | 2 | 146 | 2 | 37890593 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 2604726 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 32499570 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 12921532 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 11992722 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 3031680 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 29325037 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 15212943 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 27036131 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 21844655 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 3138230 | ||
| Pubmed | Heterologous expression of recombinant human glutathione transferase A1-1 from a hepatoma cell line. | 1.75e-05 | 2 | 146 | 2 | 1330133 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 19639209 | ||
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 22846578 | ||
| Pubmed | Characterization of two novel subunits of the alpha-class glutathione S-transferases of human liver. | 1.75e-05 | 2 | 146 | 2 | 8431482 | |
| Pubmed | 1.75e-05 | 2 | 146 | 2 | 39222175 | ||
| Pubmed | RNA-binding IMPs promote cell adhesion and invadopodia formation. | 1.75e-05 | 2 | 146 | 2 | 16541107 | |
| Pubmed | CCP110 MED14 GON4L MECOM MED13L UBN2 CDCA8 IGF2BP3 BBX AP2A1 ZNF608 MED13 | 1.93e-05 | 645 | 146 | 12 | 25281560 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ZC3H14 GATAD2A MAP4 MED14 CDCA8 SRRT IGF2BP1 IGF2BP3 AP2A1 TRIM28 MACF1 PRRC2A TOP2A | 2.04e-05 | 759 | 146 | 13 | 35915203 |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FOXS1 HDAC5 E4F1 JADE1 STAT6 ZNF263 JUND MZF1 TRIM28 GLI1 BRPF1 BRD7 NKX2-2 RERE | 2.11e-05 | 877 | 146 | 14 | 20211142 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.20e-05 | 358 | 146 | 9 | 32460013 | |
| Pubmed | ZC3H14 FKBP15 GATAD2A MAP4 MED14 MED13L SRRT NCOR1 TAF3 TRIM28 NFIB BRD4 MYO15A TOP2A MED13 | 2.56e-05 | 1014 | 146 | 15 | 32416067 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.78e-05 | 283 | 146 | 8 | 30585729 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ZC3H14 ZC3H13 NAP1L3 DAG1 MECOM NDFIP2 CDCA8 MFSD14A SRRT IGF2BP1 IGF2BP3 BRD7 PRRC2A MED13 | 3.64e-05 | 922 | 146 | 14 | 27609421 |
| Pubmed | 3.90e-05 | 16 | 146 | 3 | 8649810 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZC3H14 FKBP15 MAP4 RTN1 SCYL2 CRACD IGF2BP1 IGF2BP3 MRTFB TRIM28 MACF1 PRRC2A TOP2A AHNAK2 | 4.19e-05 | 934 | 146 | 14 | 33916271 |
| Pubmed | An expanded Oct4 interaction network: implications for stem cell biology, development, and disease. | 4.23e-05 | 91 | 146 | 5 | 20362542 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 4.24e-05 | 220 | 146 | 7 | 35785414 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 5.01e-05 | 398 | 146 | 9 | 35016035 | |
| Pubmed | 5.02e-05 | 48 | 146 | 4 | 8884266 | ||
| Pubmed | Expression of the RNA-binding protein VICKZ in normal hematopoietic tissues and neoplasms. | 5.24e-05 | 3 | 146 | 2 | 17296566 | |
| Pubmed | Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. | 5.24e-05 | 3 | 146 | 2 | 19887615 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 28813519 | ||
| Pubmed | Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. | 5.24e-05 | 3 | 146 | 2 | 29476152 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 37819742 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 11340167 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 11943463 | ||
| Pubmed | Initiation of stress granule assembly by rapid clustering of IGF2BP proteins upon osmotic shock. | 5.24e-05 | 3 | 146 | 2 | 32668274 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 29692870 | ||
| Pubmed | MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains. | 5.24e-05 | 3 | 146 | 2 | 21865464 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 20627640 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 30918291 | ||
| Pubmed | Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer. | 5.24e-05 | 3 | 146 | 2 | 16049158 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 12419962 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 9891060 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 12093480 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 32134323 | ||
| Pubmed | Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer. | 5.24e-05 | 3 | 146 | 2 | 30518851 | |
| Pubmed | VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins. | 5.24e-05 | 3 | 146 | 2 | 15601260 | |
| Pubmed | Growth factor independent-1 induced by IL-4 regulates Th2 cell proliferation. | 5.24e-05 | 3 | 146 | 2 | 12049724 | |
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 20080952 | ||
| Pubmed | 5.24e-05 | 3 | 146 | 2 | 17925019 | ||
| Pubmed | TOM1L2 MAP4 PPRC1 ZC3H13 DAG1 JADE1 UBN2 STAT6 MFSD14A KMT2C SH3PXD2B GLI1 MACF1 CDK6 BRWD1 | 5.47e-05 | 1084 | 146 | 15 | 11544199 | |
| Pubmed | CCP110 GATAD2A MAP4 ZC3H13 SRRT NCOR1 IGF2BP1 TRIM28 PRRC2A TOP2A | 5.62e-05 | 503 | 146 | 10 | 16964243 | |
| Pubmed | 5.65e-05 | 18 | 146 | 3 | 16854408 | ||
| Pubmed | ZC3H14 GATAD2A ZC3H13 SCYL2 NCOR1 JUND IGF2BP3 TRIM28 NFIB BRPF1 PRRC2A TOP2A INO80B | 6.27e-05 | 847 | 146 | 13 | 35850772 | |
| Pubmed | ZC3H14 GATAD2A MAP4 MED14 MED13L UBN2 CCDC7 NCOR1 KMT2C JUND IGF2BP1 IGF2BP3 BRD4 PRRC2A TOP2A | 6.64e-05 | 1103 | 146 | 15 | 34189442 | |
| Pubmed | 6.97e-05 | 101 | 146 | 5 | 26949739 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CCP110 MAP4 USP43 KIAA1191 NHSL1 SRRT SH3PXD2B MAST4 PI4KB BRD4 MACF1 CDC25B AHNAK2 | 7.40e-05 | 861 | 146 | 13 | 36931259 |
| Interaction | SSRP1 interactions | ZC3H14 GATAD2A ZC3H13 MECOM JADE1 TEK RTN1 SRRT NCOR1 IGF2BP1 IGF2BP3 TRIM28 BRD4 BRPF1 BRD7 INTS9 PRRC2A TOP2A BRWD1 | 2.83e-07 | 685 | 140 | 19 | int:SSRP1 |
| Interaction | H3C14 interactions | 1.46e-06 | 156 | 140 | 9 | int:H3C14 | |
| Interaction | EGR2 interactions | 3.12e-06 | 171 | 140 | 9 | int:EGR2 | |
| Interaction | TLX1 interactions | 3.78e-06 | 175 | 140 | 9 | int:TLX1 | |
| Interaction | NUP43 interactions | GATAD2A DSCAM MAP4 ZC3H13 GON4L UBN2 CDCA8 SRRT NCOR1 TAF3 MRTFB BBX ZNF608 RERE TOP2A AHNAK2 | 7.34e-06 | 625 | 140 | 16 | int:NUP43 |
| Interaction | SP7 interactions | BCL7C SRRT NCOR1 KMT2C IGF2BP1 IGF2BP3 ZNF608 NFIB BRD7 RERE FAM124B | 9.28e-06 | 304 | 140 | 11 | int:SP7 |
| Interaction | CENPA interactions | GATAD2A ZC3H13 MECOM UBN2 CDCA8 SRRT TAF3 BBX BRPF1 BRD7 TOP2A BRWD1 | 1.31e-05 | 377 | 140 | 12 | int:CENPA |
| Interaction | SOX6 interactions | 1.42e-05 | 157 | 140 | 8 | int:SOX6 | |
| Interaction | AR interactions | TOM1L2 BCL7C MED14 MED13L UBN2 SRRT NCOR1 KMT2C KDM4D ZNF608 TRIM28 NFIB BRD4 BRD7 NKX3-1 RERE REPS2 CDC25B MED13 CDK6 | 1.74e-05 | 992 | 140 | 20 | int:AR |
| Interaction | HNF4A interactions | 2.30e-05 | 275 | 140 | 10 | int:HNF4A | |
| Interaction | TOP3B interactions | NRF1 PPRC1 PIEZO1 MED14 JADE1 TNRC6C MED13L PLXNB2 NHSL1 NCOR1 KMT2C ZNF263 JUND IGF2BP1 SH3PXD2B AP2A1 ADAMTS7 PLEKHM2 TRIM28 GLI1 BRD4 PPP1R15B PRRC2A MED13 AHNAK2 | 2.57e-05 | 1470 | 140 | 25 | int:TOP3B |
| Interaction | MED14 interactions | 2.63e-05 | 171 | 140 | 8 | int:MED14 | |
| Interaction | KLF15 interactions | NRF1 NCOR1 KMT2C IGF2BP1 IGF2BP3 ZNF608 GLI1 BRD7 PRRC2A MMUT | 3.61e-05 | 290 | 140 | 10 | int:KLF15 |
| Interaction | HNRNPUL2 interactions | FOXS1 ZC3H14 MECOM TNRC6C TEK SRRT IGF2BP1 IGF2BP3 BRD4 TOP2A | 3.72e-05 | 291 | 140 | 10 | int:HNRNPUL2 |
| Interaction | BRD2 interactions | GATAD2A BCL7C MECOM ZNF263 TAF3 BRD4 NMT2 BRPF1 BRD7 TOP2A INO80B NOVA2 | 4.65e-05 | 429 | 140 | 12 | int:BRD2 |
| Interaction | MED25 interactions | 4.69e-05 | 93 | 140 | 6 | int:MED25 | |
| Interaction | SOX9 interactions | 5.94e-05 | 97 | 140 | 6 | int:SOX9 | |
| Interaction | NFIB interactions | 6.12e-05 | 142 | 140 | 7 | int:NFIB | |
| Interaction | MED27 interactions | 7.86e-05 | 102 | 140 | 6 | int:MED27 | |
| Interaction | FEV interactions | 8.86e-05 | 203 | 140 | 8 | int:FEV | |
| Interaction | MEN1 interactions | ZC3H14 GATAD2A ZC3H13 MED14 SCYL2 SRRT NCOR1 KMT2C JUND IGF2BP3 MRTFB ZNF608 TRIM28 NFIB BRPF1 INTS9 RERE PRRC2A TOP2A | 9.36e-05 | 1029 | 140 | 19 | int:MEN1 |
| Interaction | MED26 interactions | 1.03e-04 | 107 | 140 | 6 | int:MED26 | |
| Interaction | MED23 interactions | 1.03e-04 | 266 | 140 | 9 | int:MED23 | |
| Interaction | EN1 interactions | 1.20e-04 | 110 | 140 | 6 | int:EN1 | |
| Interaction | PAX8 interactions | 1.26e-04 | 111 | 140 | 6 | int:PAX8 | |
| Interaction | TBR1 interactions | 1.39e-04 | 113 | 140 | 6 | int:TBR1 | |
| Interaction | SOX5 interactions | 1.40e-04 | 162 | 140 | 7 | int:SOX5 | |
| Interaction | LHX4 interactions | 1.63e-04 | 166 | 140 | 7 | int:LHX4 | |
| Interaction | CBX3 interactions | CACNB4 ZC3H13 MECOM UBN2 CDCA8 SRRT NCOR1 ZNF263 PRDM10 BBX TRIM28 BRD4 MACF1 TOP2A | 1.66e-04 | 646 | 140 | 14 | int:CBX3 |
| Interaction | H3C1 interactions | HDAC5 GATAD2A MED14 MECOM JADE1 NEB UBN2 CDCA8 NCOR1 KMT2C TAF3 BBX TRIM28 BRD4 BRPF1 BRD7 TOP2A | 1.74e-04 | 901 | 140 | 17 | int:H3C1 |
| Interaction | RBM11 interactions | 1.82e-04 | 169 | 140 | 7 | int:RBM11 | |
| Interaction | MRE11 interactions | 1.83e-04 | 287 | 140 | 9 | int:MRE11 | |
| Interaction | SMC5 interactions | ZC3H14 GATAD2A MAP4 ZC3H13 UBN2 CDCA8 SRRT NCOR1 IGF2BP1 TAF3 BBX SNAP91 TRIM28 BRD4 BRD7 PRRC2A TOP2A INO80B | 1.99e-04 | 1000 | 140 | 18 | int:SMC5 |
| Interaction | MED8 interactions | 2.02e-04 | 121 | 140 | 6 | int:MED8 | |
| Interaction | H3-3A interactions | HDAC5 GATAD2A BCL7C UBN2 CDCA8 KMT2C TAF3 BBX TRIM28 BRD4 BRPF1 BRD7 ZNF649 TOP2A BRWD1 | 2.28e-04 | 749 | 140 | 15 | int:H3-3A |
| Interaction | CDK1 interactions | CCP110 HDAC5 NRF1 MAP4 SCYL2 IGF2BP3 TRIM28 GLI1 BRD4 REPS2 CDC25B TOP2A CDK6 | 2.45e-04 | 590 | 140 | 13 | int:CDK1 |
| Interaction | PAX6 interactions | 2.45e-04 | 366 | 140 | 10 | int:PAX6 | |
| Interaction | SENP3 interactions | 2.60e-04 | 301 | 140 | 9 | int:SENP3 | |
| Cytoband | 6p12.1 | 1.60e-04 | 33 | 146 | 3 | 6p12.1 | |
| GeneFamily | PHD finger proteins | 1.01e-04 | 90 | 93 | 5 | 88 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.58e-04 | 53 | 93 | 4 | 532 | |
| GeneFamily | Cyclins|Mediator complex | 6.43e-04 | 33 | 93 | 3 | 1061 | |
| GeneFamily | Fibronectin type III domain containing | 1.42e-03 | 160 | 93 | 5 | 555 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.43e-03 | 181 | 93 | 5 | 694 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 2.63e-03 | 15 | 93 | 2 | 82 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 3.39e-03 | 17 | 93 | 2 | 1197 | |
| GeneFamily | FKBP prolyl isomerases | 3.80e-03 | 18 | 93 | 2 | 910 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | FKBP15 CACNB4 DSCAM MFSD6 PAQR8 NPAS3 NAP1L3 RUSC1 SRCIN1 TNRC6C MED13L NEB UBN2 RTN1 TTLL7 MAST4 SNAP91 PDE4DIP ROBO1 HYDIN AHNAK2 BRWD1 | 1.51e-07 | 1106 | 143 | 22 | M39071 |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 1.42e-05 | 199 | 143 | 8 | M7325 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.26e-09 | 200 | 146 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-09 | 145 | 146 | 9 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.10e-08 | 169 | 146 | 8 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-07 | 194 | 146 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.83e-07 | 196 | 146 | 8 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.83e-07 | 196 | 146 | 8 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 3.18e-07 | 199 | 146 | 8 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.30e-07 | 200 | 146 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.40e-06 | 168 | 146 | 7 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.98e-06 | 177 | 146 | 7 | d947ba38db1772fc5fdcdc211f7511c4aa699dee | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.98e-06 | 177 | 146 | 7 | d5640f0097878f0dac671e51dc51310278bb2682 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-06 | 180 | 146 | 7 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.85e-06 | 187 | 146 | 7 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Control-Epithelial-Ciliated_cells|Control / Condition, Lineage and Cell class | 3.28e-06 | 191 | 146 | 7 | ea1d2c6838119b7019e9a2ff71d6212262b51b57 | |
| ToppCell | Control-Epithelial|Control / Condition, Lineage and Cell class | 3.28e-06 | 191 | 146 | 7 | 6228302febdb3dffe37dece7062d27ac9ccc6d4b | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 3.40e-06 | 192 | 146 | 7 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.51e-06 | 193 | 146 | 7 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.02e-06 | 197 | 146 | 7 | 491e12a5fca06b86443c0173f5fa750ea3b8a715 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.02e-06 | 197 | 146 | 7 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-06 | 199 | 146 | 7 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.30e-06 | 199 | 146 | 7 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 4.30e-06 | 199 | 146 | 7 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.30e-06 | 199 | 146 | 7 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.30e-06 | 199 | 146 | 7 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 4.30e-06 | 199 | 146 | 7 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 4.30e-06 | 199 | 146 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 4.30e-06 | 199 | 146 | 7 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 4.30e-06 | 199 | 146 | 7 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.44e-06 | 200 | 146 | 7 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.44e-06 | 200 | 146 | 7 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.44e-06 | 200 | 146 | 7 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Club_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 9.14e-06 | 147 | 146 | 6 | 5a824c89e4d045af465d7333275f8191fb29b041 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-GC_B_(II)|lymph-node_spleen / Manually curated celltypes from each tissue | 1.11e-05 | 152 | 146 | 6 | 4f690aed23338687bdefc47e8a2f3d1fdb2b6447 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.53e-05 | 161 | 146 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.59e-05 | 162 | 146 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 165 | 146 | 6 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-05 | 167 | 146 | 6 | edb722ee9b6ccd00fb038f702be8664020932659 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.09e-05 | 170 | 146 | 6 | 5bb577e2c4bd275fbe4ee23ff8c007b2fcb90e56 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-05 | 172 | 146 | 6 | c06ca5d075937747952ed915c9db39a9f62072f9 | |
| ToppCell | droplet-Lung-21m-Epithelial-airway_epithelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.30e-05 | 173 | 146 | 6 | a809be2630d2b91b53b82b5e2bb99e05524597c1 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-hematologic-hematopoietic_progenitor|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.38e-05 | 174 | 146 | 6 | 66df78280f657978c4a568010ae7d7943869af90 | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.46e-05 | 175 | 146 | 6 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.46e-05 | 175 | 146 | 6 | a154b28b0b2180652d51d4c7d804b3b81b35899e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 177 | 146 | 6 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-05 | 177 | 146 | 6 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 2.62e-05 | 177 | 146 | 6 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | severe-Others-CD34+_GATA2+_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.79e-05 | 179 | 146 | 6 | dd789a1b7327d6f9ed5272f3eb54bd43f7ae8d78 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Intestinal_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.88e-05 | 180 | 146 | 6 | 7be7d7a6906fff6dbdecd9cb013d855aba4eda2a | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.97e-05 | 181 | 146 | 6 | 070ae3f3fe0e177fabcf34e64a0f158b01354837 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_MEMP|bone_marrow / Manually curated celltypes from each tissue | 3.25e-05 | 184 | 146 | 6 | b81a2a95944cee8fec13d63dc0d95496e67aa937 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 184 | 146 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-05 | 185 | 146 | 6 | d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.35e-05 | 185 | 146 | 6 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | Ciliated_cells-B-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 3.46e-05 | 186 | 146 | 6 | f72267d533fd0c5280d9741ceee3dd116300a7e4 | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.46e-05 | 186 | 146 | 6 | 943c604a7cd873faf510096d094100512ba2d6bc | |
| ToppCell | (8)_CD34_progenitor|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.46e-05 | 186 | 146 | 6 | e69a986b8618effd61875fda528a2e44aab11868 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 187 | 146 | 6 | 0334fb1247a5800bf1438a48da8fd905df000d89 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 3.56e-05 | 187 | 146 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 3.56e-05 | 187 | 146 | 6 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.56e-05 | 187 | 146 | 6 | e61992de4f98eeea08b43213850769d923f8db48 | |
| ToppCell | droplet-Lung-LUNG-1m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-05 | 187 | 146 | 6 | cf8e3448402e1d05b8321a5f124bd29e30e18841 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.67e-05 | 188 | 146 | 6 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 3.78e-05 | 189 | 146 | 6 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | COVID-19_Severe-HSPC|World / disease group, cell group and cell class | 3.78e-05 | 189 | 146 | 6 | 555c0b13f1508b9e3712b36d77144e73e828bc76 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.78e-05 | 189 | 146 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.78e-05 | 189 | 146 | 6 | 6687a93ac8540ece5fd762f6f77c1f25f159195b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.78e-05 | 189 | 146 | 6 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.13e-05 | 192 | 146 | 6 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 4.13e-05 | 192 | 146 | 6 | cbc304c704e8524eee24a1619d0fbb2cf96c4976 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.25e-05 | 193 | 146 | 6 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.25e-05 | 193 | 146 | 6 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.25e-05 | 193 | 146 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.25e-05 | 193 | 146 | 6 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.37e-05 | 194 | 146 | 6 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.37e-05 | 194 | 146 | 6 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 4.50e-05 | 195 | 146 | 6 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 195 | 146 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-05 | 195 | 146 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 4.76e-05 | 197 | 146 | 6 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.76e-05 | 197 | 146 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 4.76e-05 | 197 | 146 | 6 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.76e-05 | 197 | 146 | 6 | 8e655db7c6f04d49927a1f0a75178e5955b4af08 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.76e-05 | 197 | 146 | 6 | 29b0a5927f80455eef7b793feabef69fba1a3df1 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.76e-05 | 197 | 146 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.90e-05 | 198 | 146 | 6 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.03e-05 | 199 | 146 | 6 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.03e-05 | 199 | 146 | 6 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.03e-05 | 199 | 146 | 6 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.03e-05 | 199 | 146 | 6 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 02594c1edbc9f2cf831639cd83363abd2551cb94 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 200 | 146 | 6 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.18e-05 | 200 | 146 | 6 | 46521d83b917b0357601db8783c8da6b73730d60 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 5.18e-05 | 200 | 146 | 6 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | (03)_Secretory-(1)_24hpi|(03)_Secretory / shred by cell type and Timepoint | 8.30e-05 | 135 | 146 | 5 | 6e473296dfe1ff7a63d701e56920c0a1b043ddc6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-Neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 8.59e-05 | 136 | 146 | 5 | b46450292e0cd549eb3bafdd3fed22f41d85bfbe | |
| Drug | Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A | 3.61e-06 | 192 | 143 | 9 | 3188_DN | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 4.09e-06 | 195 | 143 | 9 | 2867_DN | |
| Drug | Sp 1 (pharmaceutical) | HDAC5 NRF1 PPRC1 MED14 E4F1 NCOR1 JUND AP2A1 MZF1 BRD7 MMP2 ATP12A MED13 CDK6 | 9.62e-06 | 548 | 143 | 14 | CID000099040 |
| Drug | Etoposide [33419-42-0]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 1.87e-05 | 180 | 143 | 8 | 5027_DN | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.03e-05 | 182 | 143 | 8 | 3317_DN | |
| Drug | alternariol monomethyl ether | 2.82e-05 | 10 | 143 | 3 | ctd:C018206 | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 3.09e-05 | 193 | 143 | 8 | 1664_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.20e-05 | 194 | 143 | 8 | 6958_DN | |
| Drug | Colistin sulfate [1264-72-8]; Up 200; 3uM; HL60; HT_HG-U133A | 3.45e-05 | 196 | 143 | 8 | 2491_UP | |
| Drug | Chenodiol [474-25-9]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 6012_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 3.57e-05 | 197 | 143 | 8 | 3473_DN | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 3.70e-05 | 198 | 143 | 8 | 1479_DN | |
| Drug | Nifurtimox [23256-30-6]; Down 200; 14uM; HL60; HT_HG-U133A | 3.84e-05 | 199 | 143 | 8 | 2908_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; SKMEL5; HG-U133A | 3.84e-05 | 199 | 143 | 8 | 494_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.98e-05 | 200 | 143 | 8 | 5494_UP | |
| Disease | cortical surface area measurement | ZC3H13 NPAS3 MECOM LGALS12 MED13L PLXNB2 NHSL1 NCOR1 IGF2BP1 MTMR11 MAST4 ADAMTS7 NFIB ROBO1 MACF1 AKAP10 RERE FAM124B PRRC2A TNXB CDK6 | 1.08e-06 | 1345 | 137 | 21 | EFO_0010736 |
| Disease | Glioblastoma | 3.43e-05 | 79 | 137 | 5 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 4.61e-05 | 84 | 137 | 5 | C0334588 | |
| Disease | chemotherapy-induced alopecia | 6.40e-05 | 3 | 137 | 2 | EFO_0005400 | |
| Disease | spontaneous preterm birth | 1.11e-04 | 101 | 137 | 5 | EFO_0006917 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 1.28e-04 | 4 | 137 | 2 | DOID:0060158 (implicated_via_orthology) | |
| Disease | neuroimaging measurement | MPP2 GATAD2A PLXNB2 NHSL1 NCOR1 IGF2BP1 MAST4 SNAP91 NFIB ROBO1 MACF1 AKAP10 RERE SLC4A9 CDK6 | 1.39e-04 | 1069 | 137 | 15 | EFO_0004346 |
| Disease | Glioblastoma Multiforme | 1.73e-04 | 111 | 137 | 5 | C1621958 | |
| Disease | Bladder Neoplasm | 5.06e-04 | 140 | 137 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 5.23e-04 | 141 | 137 | 5 | C0005684 | |
| Disease | Prostatic Neoplasms | STARD10 DAG1 GSTA1 NCOR1 KMT2C BRD4 BRPF1 ROBO1 NKX3-1 TOP2A | 6.26e-04 | 616 | 137 | 10 | C0033578 |
| Disease | Malignant neoplasm of prostate | STARD10 DAG1 GSTA1 NCOR1 KMT2C BRD4 BRPF1 ROBO1 NKX3-1 TOP2A | 6.26e-04 | 616 | 137 | 10 | C0376358 |
| Disease | alcohol consumption measurement | TOM1L2 PIGN TMEM161B MFSD6 NPAS3 LGALS12 JADE1 STAT6 IGF2BP1 MAST4 ZNF608 SNAP91 PLEKHM2 RERE MYO15A | 6.75e-04 | 1242 | 137 | 15 | EFO_0007878 |
| Disease | cortical thickness | TOM1L2 GATAD2A MECOM LGALS12 NHSL1 IGF2BP1 SH3PXD2B MAST4 SNAP91 ADAMTS7 ROBO1 MACF1 AKAP10 RERE | 6.93e-04 | 1113 | 137 | 14 | EFO_0004840 |
| Disease | Cancer of Nasopharynx | 7.54e-04 | 9 | 137 | 2 | C0238301 | |
| Disease | Nasopharyngeal Neoplasms | 7.54e-04 | 9 | 137 | 2 | C0027439 | |
| Disease | prostate cancer (is_marker_for) | 8.26e-04 | 156 | 137 | 5 | DOID:10283 (is_marker_for) | |
| Disease | aspartate aminotransferase measurement | PIEZO1 STARD10 HPSE2 ITIH1 TTLL7 GLI1 ROBO1 FKBP7 MYO15A PRRC2A MMUT CDK6 | 1.07e-03 | 904 | 137 | 12 | EFO_0004736 |
| Disease | glioblastoma (is_marker_for) | 1.13e-03 | 44 | 137 | 3 | DOID:3068 (is_marker_for) | |
| Disease | Intellectual Disability | 1.19e-03 | 447 | 137 | 8 | C3714756 | |
| Disease | Abnormality of refraction | MPP2 DSCAM ABHD6 ZNF608 SNAP91 ROBO1 NKX2-2 RERE MMP2 CREB3L2 | 1.22e-03 | 673 | 137 | 10 | HP_0000539 |
| Disease | schizophrenia, anorexia nervosa | 1.45e-03 | 48 | 137 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | Malignant neoplasm of breast | PCDHB15 MED14 MECOM TEK NME8 NCOR1 GLI1 ROBO1 MACF1 MMP2 REPS2 PRRC2A TOP2A | 1.52e-03 | 1074 | 137 | 13 | C0006142 |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.60e-03 | 364 | 137 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | 1,3,7-trimethylurate measurement | 2.16e-03 | 15 | 137 | 2 | EFO_0021172 | |
| Disease | femoral neck bone mineral density | 2.26e-03 | 196 | 137 | 5 | EFO_0007785 | |
| Disease | bone density | 2.30e-03 | 388 | 137 | 7 | EFO_0003923 | |
| Disease | focal segmental glomerulosclerosis | 2.46e-03 | 16 | 137 | 2 | EFO_0004236 | |
| Disease | preeclampsia, parental genotype effect measurement | 2.46e-03 | 16 | 137 | 2 | EFO_0000668, EFO_0005939 | |
| Disease | migraine without aura, susceptibility to, 4 | 2.46e-03 | 16 | 137 | 2 | MONDO_0011847 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 2.47e-03 | 200 | 137 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Liver carcinoma | 2.61e-03 | 507 | 137 | 8 | C2239176 | |
| Disease | cognitive function measurement | DSCAM MAP4 PIEZO1 TMEM161B STARD10 PLXNB2 TTLL7 IGF2BP1 BBX MAST4 ZNF608 NFIB FHDC1 TNXB HYDIN | 2.77e-03 | 1434 | 137 | 15 | EFO_0008354 |
| Disease | ocular hypertension (biomarker_via_orthology) | 2.78e-03 | 17 | 137 | 2 | DOID:9282 (biomarker_via_orthology) | |
| Disease | irritable bowel syndrome | 3.31e-03 | 131 | 137 | 4 | EFO_0000555 | |
| Disease | comparative body size at age 10, self-reported | 3.56e-03 | 420 | 137 | 7 | EFO_0009819 | |
| Disease | diet measurement | MPP2 DSCAM NRF1 MFSD6 NPAS3 HPSE2 ZKSCAN2 SCYL2 ZNF608 ROBO1 AKAP10 RERE | 3.64e-03 | 1049 | 137 | 12 | EFO_0008111 |
| Disease | coronary artery disease | DSCAM USP43 MECOM TEK NFU1 CRACD IGF2BP1 MAST4 ADAMTS7 NFIB NANOS3 CFAP161 TNXB | 3.79e-03 | 1194 | 137 | 13 | EFO_0001645 |
| Disease | number of teeth measurement | 3.85e-03 | 20 | 137 | 2 | EFO_0010073 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 4.24e-03 | 21 | 137 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 4.24e-03 | 21 | 137 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | HbA1c measurement | 4.37e-03 | 675 | 137 | 9 | EFO_0004541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AVEKIPLIPSTPEEM | 196 | Q9BV23 | |
| AESMPPAESVPLIGK | 286 | Q9GZZ6 | |
| MEPSQSLPEKGPVTI | 936 | Q68DN1 | |
| MPEEERSIPEKGLEP | 941 | Q96Q91 | |
| GETPEGIKAEPLTPM | 566 | Q8WY36 | |
| GIKAEPLTPMEDALP | 571 | Q8WY36 | |
| DKIEPMVLRSPPTGE | 46 | Q96M83 | |
| EMKPVDVGRPVIRPP | 1151 | O60885 | |
| AKEMEITEVEPPGRL | 496 | Q9NPI1 | |
| ISPDAAKPIPITEAM | 306 | O43572 | |
| EMPPFPERESSILAK | 601 | O95782 | |
| VEILLAMKPPGDVPE | 1246 | Q8IYW2 | |
| PEPLQRPEMLKEETR | 111 | Q9H467 | |
| KVPEPGVPTETIKDM | 111 | Q00534 | |
| PELDLFAMKPPETSV | 491 | O60641 | |
| LPKPPTEDTRAMEQA | 281 | Q6P656 | |
| VPSMRPVVLVGPSLK | 216 | O00305 | |
| PEMKVRDSSLEPGTP | 1301 | Q9UKP4 | |
| TVTPRDKPMGPLLVA | 496 | P08253 | |
| PEPMLEPDQKRSLES | 36 | P60323 | |
| RPKTISIDENMEPSP | 271 | O00712 | |
| GSPRKPPMDEKSLEE | 201 | P08263 | |
| ELADSLVPMEIKPGI | 521 | Q9NV88 | |
| RSLPLKMEPQSPGEV | 716 | Q03112 | |
| DMKSERRPPSPDVIV | 91 | Q86YP4 | |
| SMRTDLPPVAKAPGI | 1046 | Q9C0D6 | |
| ESRPPKLVMESVTLP | 681 | Q8NEZ4 | |
| PAASIEMTLKNPERP | 1776 | Q71F56 | |
| ETEMALGKDVTPPPE | 511 | P27816 | |
| LPDVTKTSGLRPMEP | 331 | O60551 | |
| PGKPVLETRTMDFPT | 76 | Q9UMS0 | |
| KPSEDSPPLEMLGPR | 626 | P19827 | |
| SGSRKPPIPLMETAE | 186 | A4FU01 | |
| GMDPEKPGTPIVLRR | 616 | Q9UKN7 | |
| GAKELDIMSNTPPPR | 296 | Q8WWW8 | |
| IAPPETPDSKVRMVI | 441 | Q9NZI8 | |
| TPDSKVRMVIITGPP | 446 | Q9NZI8 | |
| MIDPPRSTVPDAVTK | 606 | P54707 | |
| PPLSPIDMDTQERIK | 256 | P17535 | |
| RLEVSMVKPTPGLTP | 176 | Q53HL2 | |
| TETMAPPVRDPVPGK | 351 | Q14118 | |
| GSPRKPPMDEKSLEE | 201 | P09210 | |
| KEETSRPPMPLITTE | 1061 | Q5SYE7 | |
| MDKEVPKGSPREPAL | 1 | P0DPP9 | |
| VMITGKLDIPEPRRP | 1296 | O15031 | |
| TVMSPGEKLDPIPDS | 21 | Q96DT0 | |
| EDEVSMKGRPPPTPL | 1191 | Q5T1M5 | |
| IKEEPSPISKMRPVT | 916 | Q9ULH7 | |
| PPLTIDGIPVSVDKM | 186 | Q16656 | |
| LPEDGALMDKPVPLS | 491 | Q6B0I6 | |
| PPGMESLISAPLVKT | 286 | P30305 | |
| ESRLTVPEGAMKPQP | 426 | P08151 | |
| PVPPDAVRMVGIRKT | 156 | Q14168 | |
| PDMKIEEVPELTLPI | 751 | Q9NQV6 | |
| PEVPALEASAPLGKM | 6 | Q96A73 | |
| PEFPEREMTLKIPET | 131 | Q9Y5E8 | |
| PLVMVDDGTLPELKP | 546 | Q8WWQ2 | |
| DKTMLAERIPVPSSP | 631 | Q6ZSS7 | |
| MEPEAPDSRKRPLET | 1 | Q9UNW9 | |
| PVPDFTIMKTEVPGS | 341 | P34949 | |
| APDAKVRMVIITGPP | 446 | O00425 | |
| MPPLIPAEVDKIREC | 5916 | Q9UPN3 | |
| LVAVPESLPEKMRPA | 206 | Q96MC6 | |
| EGCPPPALTEEMLLK | 201 | Q9C086 | |
| PPLPASDSKLVERAM | 376 | O60244 | |
| LEDGLPKMPCTVPET | 26 | Q8TEZ7 | |
| EDSLSRKPDPEPGRM | 81 | Q9NV92 | |
| RPPPVSELATKGTMV | 1041 | Q96QU1 | |
| RGPTELLSPLVMPSE | 566 | B2RXH4 | |
| TDMCPGEKRKVVIPP | 101 | Q9Y680 | |
| LPPGMSVDPKESSVL | 191 | Q9H5Z6 | |
| PVKRPPLTMTDDLEH | 2621 | Q4G0P3 | |
| EPPKLLETVRFPLME | 236 | Q53GT1 | |
| PMLTKEEPVPELLEA | 161 | Q8WUZ0 | |
| MPILEQKLEPGTEPL | 1221 | Q9P218 | |
| ESKMQITPETPGRIP | 6 | Q6PGQ7 | |
| RKRPMLGPSEETAPQ | 746 | Q6ZU35 | |
| PTPGDLEEIVKMEPE | 1316 | Q3T8J9 | |
| VPEIMPKLPTDLAGV | 421 | O43303 | |
| KMPPLVSPQDRTEEE | 61 | A0A1B0GTR0 | |
| GPMLDKEIPPSISRV | 86 | Q9NSI6 | |
| GAKEPMAEVTPPPVR | 101 | A6NNA5 | |
| MGEKVSEAPEPVPRG | 1 | O15021 | |
| TTDGRPRPPMEPKEI | 181 | O43638 | |
| MDKEVPKGSPREPAL | 1 | Q3ZM63 | |
| ELSLGMKALAPEPPV | 341 | Q66K89 | |
| TVEVKPVLPRAMPSS | 31 | Q9UQL6 | |
| PVTGPQAPTIKELMR | 16 | P51170 | |
| PKKMPALVIPEVGSR | 1306 | Q5VV67 | |
| VTVLVERVMPPPKLD | 551 | O75309 | |
| TPLEKEEPPLEMNTG | 151 | Q70SY1 | |
| PLTIGKEVTMDVPAP | 246 | Q86XP0 | |
| SERSEPGLLIPEMKD | 386 | Q8IWE5 | |
| MSKIRGLPPEVREPG | 1 | Q6NXP2 | |
| TLKRPTVLEPIPMEA | 1936 | O60469 | |
| SVLALVKRGAPPEMP | 816 | Q9BVN2 | |
| DSPPMKPSALDAIRE | 486 | Q16799 | |
| GALEPETPMLPRKPE | 541 | Q16799 | |
| LDSPEAEELPAMKRP | 181 | Q5VWG9 | |
| EEPSPPSIRRKMEID | 711 | Q9HCJ0 | |
| MEKLAASTEPQGPRP | 1 | Q9Y365 | |
| MRAPIPEPKPGDLIE | 1 | P53816 | |
| PPLGKESIPLMTEAT | 296 | Q8NDZ6 | |
| MPEKRLTAEPPTITE | 1 | Q8NE09 | |
| SKLSRGMPPLEIVPE | 1411 | O75376 | |
| LPPGLMEAKVRVLDP | 171 | Q6UWY2 | |
| MLRERGTPPVDPKLA | 776 | P48634 | |
| TPTVRPDADQMTKIP | 311 | Q6P3W7 | |
| SKPDGPMVAVAEPVR | 451 | Q8NG04 | |
| ARAEKGMEVTPLPSP | 186 | O95096 | |
| MLRVPEPRPGEAKAE | 1 | Q99801 | |
| PEIPMIGKLEPREDA | 446 | Q99457 | |
| LRMEGPPPNTSVKVI | 116 | Q8IXF0 | |
| ERMKPGFEVKPPELD | 1321 | Q9P2R6 | |
| PDPLVPSKPMEDRID | 566 | Q9UHV7 | |
| IPEVSIGSPEKMEPI | 286 | Q6IE81 | |
| PSSEIPMEKEPGEGR | 386 | Q5SWA1 | |
| MGDTVVEPAPLKPTS | 1 | Q9UBF8 | |
| SIAEIDLGVPPPVMK | 136 | Q9BXP5 | |
| PVPPLEVLKLGEQMT | 1121 | P55201 | |
| VDVSPPKVEADMSLP | 2176 | Q8IVF2 | |
| PRKFDLPLTVMPSVE | 926 | Q70EL4 | |
| SMPTTKPRPGLREEK | 791 | Q6ZU65 | |
| MGPTDPEEAKLLSPD | 536 | Q8N427 | |
| SIEEAMKRGEDPPTP | 466 | Q8NFH8 | |
| GPPVPAKDTETRERM | 556 | Q9C0H9 | |
| RIIPKIMPEKPAEEG | 106 | Q7RTT6 | |
| ISDPDMEEKPSLPPR | 511 | A1X283 | |
| IKMTVERDQPLPTPE | 646 | P42226 | |
| PGLSKMEPQTPDISL | 326 | A6NH21 | |
| MTPEPPIKPRLGELT | 2621 | P22105 | |
| LEVRPVVVPKLPSMD | 1501 | Q9Y6N7 | |
| PLPTNEEMTLVKPDG | 376 | Q02763 | |
| PLMPVVGRKPDISLV | 606 | O95427 | |
| EPMLNGTEKTPPLIT | 941 | P11388 | |
| KPTIMGEPITVNPAL | 791 | Q9ULD9 | |
| RAPSTDKPKEMIPVP | 431 | Q63HK3 | |
| MDLRPELPTTLGPVS | 486 | Q92508 | |
| PEIMDLSELRPFSKP | 1241 | Q9Y4F4 | |
| ERAKAAEMVPDLPSP | 466 | Q6ZVM7 | |
| MSTVKPLREPAPSED | 156 | Q6PJT7 | |
| IPTRLPKMEVRAEEP | 66 | A6NL46 | |
| RGPKPLCSMPESTEI | 526 | Q6ZT98 | |
| PTVPLGARMSIKDDP | 756 | A6NCI4 | |
| PRTPPITTKEELVEM | 1031 | Q5T200 | |
| PTATEGPETKPVLMA | 566 | Q13263 | |
| MPTEIEFPESRKPIS | 146 | Q9BS31 | |
| FKLEPMETERSPGPR | 156 | O14978 | |
| RDTMDLPEELPGVKP | 76 | P22033 | |
| LDTSPVMKTPPKLEG | 2151 | Q5VU43 | |
| RAPPEDEGPVMVKLE | 11 | P28698 | |
| LGKGIPTPITPEMER | 6251 | P20929 |